Home/SyzOnc/Ashley M. Fuller, PhD

AM

Ashley M. Fuller, PhD

Co-founder & CSO

Therapeutic Areas

Oncology Immunology

SyzOnc Pipeline

Drug	Indication	Phase
STEM³ Platform Validation & Target Discovery	Matrix-rich solid tumors (e.g., Sarcoma)	Discovery

Leadership Team at SyzOnc

T. S. Karin Eisinger, PhD

Co-founder & CEO

Anne Carpenter, PhD

Co-founder & Chair of SAB

Arindam Mondal, PhD

Senior Scientist

View full SyzOnc profile